TMDX · TransMedics Group, Inc.
$76.08
-1.92 (-2.46%)
At close · Jul 30
Market Cap
$2.58B
Shares
34.56M
TransMedics Group, Inc. Earnings Call Transcripts
Every quarterly earnings call for TransMedics Group, Inc. (TMDX) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲151.1%
$20.52M
−$11.52M
'22 Q2
22-08-01
▲378.3%
$25.68M
−$7.43M
'22 Q3
22-11-03
▲224.5%
$31.38M
−$6.72M
'22 Q4
23-02-22
▲161.7%
$41.55M
−$2.64M
'23 Q1
23-05-01
▲155.7%
$52.47M
−$1.00M
'23 Q2
23-08-03
▲158.7%
$66.43M
−$25.42M
'23 Q3
23-11-06
▲158.7%
$81.17M
$4.03M
'23 Q4
24-02-26
▲133.1%
$96.85M
$12.20M
'24 Q1
24-04-30
▲117.9%
$114.31M
$12.19M
'24 Q2
24-07-31
▲63.7%
$108.76M
$4.22M
'24 Q3
24-10-28
▲49.8%
$121.62M
$6.86M
'24 Q4
25-02-27
▲48.2%
$143.54M
$25.68M
'25 Q1
25-05-08
▲37.7%
$157.37M
$34.91M
'25 Q2
25-07-30
▲32.2%
$143.82M
$24.32M
'25 Q3
25-10-29
▲32.2%
$160.76M
$105.38M
'25 Q4
26-02-24
LATEST
▲21.2%
$173.93M
$7.32M
'26 Q1
26-05-05
Earnings call
FY26 · Q1
2026-05-05
TransMedics Group, Inc. Q1 FY2026 Earnings Call
Confident tone
ENHANCE Heart and DENOVO Lung Trials
CHOPS Cold Storage Device
Full-Year Revenue Guidance
Revenue
$173.93M
▲ 21.2% YoY Diluted EPS
$0.20
▼ 71.4% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
TransMedics Group, Inc. Q4 FY2025 Earnings Call
Confident tone
2026 Margin / Investment Guidance
OPO / CMS Regulatory Landscape
ENHANCE Heart and DENOVO Lung Clinical Programs
Revenue
$160.76M*
▲ 32.2% YoY Gross margin
58.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
TransMedics Group, Inc. Q3 FY2025 Earnings Call
Confident tone
Competitive Landscape / OrganOx Acquisition
International / Italy NOP Expansion
Seasonality and Market Softness
Revenue
$143.82M
▲ 32.2% YoY Diluted EPS
$0.66
▲ 450% YoY Gross margin
58.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
TransMedics Group, Inc. Q2 FY2025 Earnings Call
Confident tone
Summer seasonality and Q3 outlook / guidance
National Transplant Modernization initiative and tariffs
Kidney OCS platform and international NOP expansion
Revenue
$157.37M
▲ 37.7% YoY Diluted EPS
$0.92
▲ 162.9% YoY Gross margin
61.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
TransMedics Group, Inc. Q1 FY2025 Earnings Call
Confident tone
OCS NOP Commercial Growth
Next-Gen OCS Heart and Lung Clinical Programs
2025 Outlook and Guidance
Revenue
$143.54M
▲ 48.2% YoY Diluted EPS
$0.70
▲ 100% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
TransMedics Group, Inc. Q4 FY2024 Earnings Call
Confident tone
Q4 and Full Year 2024 Results
2025 Financial Guidance
Transplant Logistics / Aviation Fleet Expansion
Revenue
$121.62M*
▲ 49.8% YoY Gross margin
59.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-28
TransMedics Group, Inc. Q3 FY2024 Earnings Call
Positive tone
Revenue growth and mix (U.S. vs OUS)
Competitive dynamics (NRP) and pricing
International / OUS expansion
Revenue
$108.76M
▲ 63.7% YoY Diluted EPS
$0.12
Gross margin
55.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
TransMedics Group, Inc. Q2 FY2024 Earnings Call
Confident tone
Revenue Growth and Financial Performance
Transplant Logistics Network Expansion
Clinical Pipeline (Lung and Heart Programs)
Revenue
$114.31M
▲ 117.9% YoY Diluted EPS
$0.35
Gross margin
60.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
TransMedics Group, Inc. Q1 FY2024 Earnings Call
Confident tone
NOP and transplant logistics / aviation fleet
OCS clinical programs and pipeline
Revenue growth and guidance raise
Revenue
$96.85M
▲ 133.1% YoY Diluted EPS
$0.35
Gross margin
61.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-26
TransMedics Group, Inc. Q4 FY2023 Earnings Call
Confident tone
National OCS transplant program (NOP)
TransMedics logistics services
Gross margin trajectory
Revenue
$81.17M*
▲ 158.7% YoY Gross margin
59.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-06
TransMedics Group, Inc. Q3 FY2023 Earnings Call
Revenue
$66.43M
▲ 158.7% YoY Diluted EPS
$-0.78
Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
TransMedics Group, Inc. Q2 FY2023 Earnings Call
Revenue
$52.47M
▲ 155.7% YoY Diluted EPS
$-0.03
Gross margin
70.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-01
TransMedics Group, Inc. Q1 FY2023 Earnings Call
Revenue
$41.55M
▲ 161.7% YoY Diluted EPS
$-0.08
Gross margin
69.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
TransMedics Group, Inc. Q4 FY2022 Earnings Call
Revenue
$31.38M*
▲ 224.5% YoY Gross margin
66.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
TransMedics Group, Inc. Q3 FY2022 Earnings Call
Revenue
$25.68M
▲ 378.3% YoY Diluted EPS
$-0.25
Gross margin
70.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-01
TransMedics Group, Inc. Q2 FY2022 Earnings Call
Revenue
$20.52M
▲ 151.1% YoY Diluted EPS
$-0.41
Gross margin
69.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
TransMedics Group, Inc. Q1 FY2022 Earnings Call
Revenue
$15.88M
▲ 125.2% YoY Diluted EPS
$-0.38
Gross margin
76.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-23
TransMedics Group, Inc. Q4 FY2021 Earnings Call
Revenue
$9.67M*
▲ 26.8% YoY Gross margin
72.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
TransMedics Group, Inc. Q3 FY2021 Earnings Call
Revenue
$5.37M
▼ 24.3% YoY Diluted EPS
$-0.47
Gross margin
70.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
TransMedics Group, Inc. Q2 FY2021 Earnings Call
Revenue
$8.17M
▲ 141% YoY Diluted EPS
$-0.39
Gross margin
68.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
TransMedics Group, Inc. Q1 FY2021 Earnings Call
Revenue
$7.05M
▼ 6.3% YoY Diluted EPS
$-0.29
Gross margin
68.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
TransMedics Group, Inc. Q4 FY2020 Earnings Call
Revenue
$7.63M
▲ 25.9% YoY Gross margin
63.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-04
TransMedics Group, Inc. Q3 FY2020 Earnings Call
Revenue
$7.09M
▼ 1.6% YoY Diluted EPS
$-0.19
Gross margin
71.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
TransMedics Group, Inc. Q2 FY2020 Earnings Call
Revenue
$3.39M
▼ 40.2% YoY Diluted EPS
$-0.36
Gross margin
56.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-04-13
TransMedics Group, Inc. Q1 FY2020 Earnings Call
Revenue
$7.53M
▲ 61% YoY Diluted EPS
$-0.42
Gross margin
64.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-04
TransMedics Group, Inc. Q4 FY2019 Earnings Call
Revenue
$6.06M
▲ 70.9% YoY Gross margin
61.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–26 of 26 earnings calls
Key facts
CIK
1756262
CUSIP
89377M109
13F (30d)
101 filings
101 filers
Visit website
Investor relations